Arda Biomaterials

Arda Biomaterials

Private
London, EnglandEnergy & Sustainabilityhttps://arda.bio

Last Round

Seed

Apr 29, 2025

Total Funding Raised

$6.65M

Momentum Score

25 /100

Company Overview

Arda Biomaterials is a chemistry technology company that develops sustainable biomaterials to reduce reliance on animal products and petrochemicals. The company's flagship product, New Grain™, is a plastic-free and animal-free leather alternative created by upcycling spent barley grain from breweries and distilleries. Using a proprietary supramolecular chemistry process, Arda transforms waste proteins into high-performance materials that mimic the structure of animal proteins. The company targets the fashion, automotive, and home goods industries, offering a scalable and circular solution that can achieve price parity with traditional leather. Founded in 2022 by Brett Cotten and Dr. Edward (TJ) Mitchell, the London-based startup has secured venture capital funding to advance its research and development and scale production.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Advanced Materials, Circular Economy, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

leather alternativevegan leatherbiomaterialplant-based leathersustainable materialplastic-free leatherupcycled materialsbrewers' spent grainBSGcircular economywaste valorizationfashion materialsnext-gen materialsbiodegradable materialautomotive materialsplant proteinsupramolecular chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arda Biomaterials Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arda Biomaterials Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 29, 2025
Pre SeedJun 12, 2023

Key People

Founding team and executive leadership

TJ Edward Mitchell

Co-Founder CTO

Founding Team

Brett Cotten

Co-Founder CEO

Founding Team

Arda Biomaterials Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Developing New Grain, a plastic-free material from natural by-products.

  • Apr 29, 2025

    $5.25M raised in Seed round.

Arda Biomaterials Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arda Biomaterials Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arda Biomaterials's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range20
Year Founded2022
Last FundingApr 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.